We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

71 hedge funds and large institutions have $373M invested in Korro Bio in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 19

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

4% more funds holding

Funds holding: 68 → 71 (+3)

0.09% more ownership

Funds ownership: 1.07% → 1.15% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $382M → $373M (-$9.3M)

Holders
71
Holders Change
+3
Holders Change %
+4.41%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
27
Reduced
19
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WA
Wasatch Advisors
Utah
+$27.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.19M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$7.5M
4
RI
RTW Investments
New York
+$6.44M
5
PA
Perceptive Advisors
New York
+$4.77M

Top Sellers

1
Allianz Asset Management
Allianz Asset Management
Germany
-$1.78M
2
HighTower Advisors
HighTower Advisors
Illinois
-$1.61M
3
BCM
Burrage Capital Management
Massachusetts
-$1.5M
4
Morgan Stanley
Morgan Stanley
New York
-$1.48M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$65.6M +$27.1M +25,275 +59%
PA
2
Perceptive Advisors
New York
$62.6M +$4.77M +4,444 +7%
RI
3
RTW Investments
New York
$47.3M +$6.44M +6,000 +14%
BlackRock
4
BlackRock
New York
$30.4M -$450K -419 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$27.8M +$8.19M +7,632 +36%
Federated Hermes
6
Federated Hermes
Pennsylvania
$26.2M +$85.9K +80 +0.3%
BBA
7
Baker Bros. Advisors
New York
$18.2M +$82.7K +77 +0.4%
MICM
8
Matthews International Capital Management
California
$9.15M – – –
MS
9
Mizuho Securities
Japan
$9.05M -$38.6K -36 -0.4%
State Street
10
State Street
Massachusetts
$8.53M +$88K +82 +0.9%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$8.02M +$3.68M +3,427 +70%
Neuberger Berman Group
12
Neuberger Berman Group
New York
$7.7M +$7.5M +6,983 +675%
Northern Trust
13
Northern Trust
Illinois
$6.1M +$59K +55 +0.9%
SDIC
14
South Dakota Investment Council
South Dakota
$5.86M +$1.27M +1,180 +24%
Charles Schwab
15
Charles Schwab
California
$3.68M +$2.16M +2,011 +111%
LCM
16
Laurion Capital Management
New York
$2.79M – – –
BCM
17
Burrage Capital Management
Massachusetts
$2.58M -$1.5M -1,395 -34%
Stifel Financial
18
Stifel Financial
Missouri
$2.46M – – –
GIM
19
Granahan Investment Management
Massachusetts
$2.26M +$189K +176 +8%
MS
20
Maven Securities
Jersey
$2.13M +$2.39M +2,222 New
N
21
Nuveen
North Carolina
$1.92M -$470K -438 -18%
DCM
22
Driehaus Capital Management
Illinois
$1.65M +$1.85M +1,722 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.63M +$41.9K +39 +2%
Ohio Public Employees Retirement System (OPERS)
24
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.6M +$598K +557 +50%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$1.36M – – –
1
2 3 4

KRRO Hedge Fund Activity: Q3 2020 in Review

71 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2020, worth a combined $373M — down 2.4% from $382M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KRRO positions and 8 closed out — a net gain of 3 holders — while 27 added to existing stakes and 19 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $27.1M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $1.78M sold.

  • 71 institutional investors held Korro Bio (KRRO) as of Q3 2020, up from 68 in Q2 2020.
  • Funds reported $373M of Korro Bio stock for Q3 2020, down 2.4% quarter-over-quarter.
  • 11 funds opened new Korro Bio positions in Q3 2020 and 8 closed out, a net change of +3 holders.
  • The largest Korro Bio buyer in Q3 2020 was Wasatch Advisors, an estimated $27.1M added.
  • The largest Korro Bio seller in Q3 2020 was Allianz Asset Management, an estimated $1.78M sold.

Based on aggregated 13F filings for Q3 2020.